Pathstone Holdings’s Kronos Bio KRON Stock Holding History

Pathstone Holdings’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,034	Closed	-$9.93K	–	2267
2025 Q1	$9.93K	Hold	12,034	–	–	﹤0.01%	2217
2024 Q4	$11.4K	Hold	12,034	–	–	﹤0.01%	2296
2024 Q3	$12K	Hold	12,034	–	–	﹤0.01%	2322
2024 Q2	$14.9K	Buy	12,034 +50	+0.4%	+$51	﹤0.01%	2293
2024 Q1	$15.6K	Sell	11,984 -50	-0.4%	-$57	﹤0.01%	2286
2023 Q4	$15K	Buy	+12,034	New	+$13.3K	﹤0.01%	2189

Pathstone Holdings's KRON Position: Q2 2025 in Review

Pathstone Holdings sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 12,034 shares — an estimated $9.93K sold.

Pathstone Holdings first reported a position in KRON in Q4 2023 and held it in 6 quarters. The position peaked at $15.6K in Q1 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

Pathstone Holdings reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
Pathstone Holdings sold 12,034 Kronos Bio shares in Q2 2025, an estimated $9.93K.
Pathstone Holdings first reported a position in Kronos Bio in Q4 2023 and held it in 6 quarters.
Pathstone Holdings's Kronos Bio position peaked at $15.6K in Q1 2024.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.